EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B ( CHB)

被引：0
|
作者：
Schwarz, Kathleen B. [1 ]
Bezerra, Jorge A. [2 ]
Choe, Byung Ho [3 ,4 ]
Lin, Chuan-Hao [5 ]
Abramov, Frida [6 ]
Wang, Hongyuan [6 ]
Liu, Yang [6 ]
Flaherty, John F. [6 ]
Pacurar, Daniela [7 ]
Kim, Kyung Mo [8 ]
Khaertynova, Ilsiyar [9 ]
Shalimar [10 ]
Wu, Jia-Feng [11 ]
Tandon, Manish [12 ]
Rosenthal, Philip [13 ]
Morozov, Viacheslav [14 ]
Sokal, Etienne M. [15 ]
Chang, Mei Hwei [16 ,17 ]
机构：
[1] Univ Calif San Diego, Rady Childrens Hosp San Diego, San Diego, CA 92103 USA
[2] Univ Texas Southwestern Med Ctr, Dallas, TX USA
[3] Kyungpook Natl Univ, Sch Med, Daegu, South Korea
[4] Kyungpook Natl Univ Childrens Hosp, Daegu, South Korea
[5] Childrens Hosp Los Angeles, Los Angeles, CA USA
[6] Gilead Sci Inc, Foster City, CA USA
[7] Carol Davila Univ Med & Pharm, Bucharest, Romania
[8] Univ Ulsan, Asan Med Ctr, Childrens Hosp, Seoul, South Korea
[9] Kazan State Med Univ, Kazan, Russia
[10] All India Inst Med Sci, Delhi, India
[11] Natl Taiwan Univ Hosp, Taipei, Taiwan
[12] MV Hosp & Res Ctr, Lucknow, Uttar Pradesh, India
[13] Univ Calif San Francisco, San Francisco, CA 94143 USA
[14] Hepatolog Med Co, Samara, Russia
[15] Clin Univ St Luc, Brussels, Belgium
[16] Natl Taiwan Univ, Taipei, Taiwan
[17] Children Hosp, Taipei, Taiwan
来源：
HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1414C
引用
收藏
页码：S515 / S517
页数：3
相关论文
共 50 条
  • [41] Tenofovir Alafenamide: A Review in Chronic Hepatitis B
    Lesley J. Scott
    Henry L. Y. Chan
    Drugs, 2017, 77 : 1017 - 1028
  • [42] SWITCHING FROM TENOFOVIR DISOPROXIL FUMARATE (TDF) AND/OR OTHER ORAL ANTIVIRALS (OAVS) TO TENOFOVIR ALAFENAMIDE (TAF) IN VIRALLY SUPPRESSED CHRONIC HEPATITIS B (CHB) PATIENTS WITH HEPATIC IMPAIRMENT: FINAL 2-YEAR EFFICACY AND SAFETY RESULTS FROM A PHASE 2
    Lim, Young-Suk
    Lin, Chun-Yen
    Heo, Jeong
    Bae, Ho
    Chuang, Wan-Long
    Yin, Tak
    Tsang, Owen
    Fournier, Claire
    Hui, Aric Josun
    Trinh, Huy
    Chan, Carol Yee Kwan
    Tan, Susanna K.
    Zhao, Yang
    Flaherty, John F.
    Suri, Vithika
    Gaggar, Anuj
    Brainard, Dianna M.
    Ryder, Stephen
    La Janssen, Harry
    GUT, 2021, 70 : A77 - A77
  • [43] Three Year Efficacy and Safety of Tenofovir Alafenamide (TAF) Compared to Tenofovir Disoproxil Fumarate (TDF) in Hbeag-Negative and Hbeag-Positive Patients with Chronic Hepatitis B
    Chan, Henry Lik Yuen
    Lim, Young-Suk
    Seto, Wai Kay Walter
    Agarwal, Kosh
    Brunetto, Maurizia R.
    Janssen, Harry L. A.
    Caruntu, Florin
    Stepanova, Tatjana
    Tsang, Owen
    Yatsuhashi, Hiroshi
    Tak, Won Young
    Chen, Chi-Yi
    Celen, Mustafa
    Suri, Vithika
    Flaherty, John F.
    Lin, Lanjia
    Cathcart, Andrea
    Gaggar, Anuj
    Pan, Calvin Q.
    Shalimar
    Buti, Maria
    HEPATOLOGY, 2018, 68 : 227A - 228A
  • [44] Tenofovir Alafenamide: A Review in Chronic Hepatitis B
    Scott, Lesley J.
    Chan, Henry L. Y.
    DRUGS, 2017, 77 (09) : 1017 - 1028
  • [45] A PHASE 3 STUDY COMPARING SWITCHING FROM TENOFOVIR DISOPROXIL FUMARATE (TDF) TO TENOFOVIR ALAFENAMIDE (TAF) WITH CONTINUED TDF TREATMENT IN VIROLOGICALLY-SUPPRESSED PATIENTS WITH CHRONIC HEPATITIS B (CHB): WEEK 48 EFFICACY AND SAFETY RESULTS
    Chan, Henry Lik Yuen
    Lampertico, Pietro
    Buti, Maria
    Fung, Scott
    Ahn, Sang Hoon
    Chuang, Wan-Long
    Tak, Won Young
    Ramji, Alnoor
    Chen, Chi-Yi
    Tam, Edward
    Bae, Ho
    Ma, Xiaoli
    Flaherty, John
    Gaggar, Anuj
    Lau, Audrey
    Feierbach, Becket
    Wu, George
    Suri, Vithika
    Subramanian, Mani
    Huy Trinh
    Yoon, Seung-Kew
    Agarwal, Kosh
    Lim, Young-Suk
    GUT, 2019, 68 : A142 - A143
  • [46] SAFETY AND EFFICACY OF TENOFOVIR ALAFENAMIDE FUMARATE USED DURING WHOLE PREGNANCY IN WOMEN WITH CHRONIC HEPATITIS B
    Xie, Yao
    Yi, Wei
    HEPATOLOGY, 2021, 74 : 515A - 516A
  • [47] Safety and Efficacy of Tenofovir Alafenamide Fumarate in Early-Middle Pregnancy for Mothers With Chronic Hepatitis B
    Chen, Ruochan
    Zou, Ju
    Long, Liyuan
    Huang, Haiyue
    Zhang, Min
    Fan, Xuegong
    Huang, Yan
    FRONTIERS IN MEDICINE, 2022, 8
  • [48] A phase 3 study of tenofovir alafenamide (TAF) compared with tenofovir disoproxil fumarate (TDF) in patients with HBeAg-positive chronic HBV (CHB): Week 48 efficacy and safety results
    Strasser, S.
    Roberts, S.
    Angus, P.
    Chan, H. L. Y.
    Fung, S.
    Seto, W. K.
    Chuang, W. L.
    Chen, C. Y.
    Kim, H. J.
    Hui, A. J.
    Janssen, H. L. A.
    Chowdhury, A.
    Tsang, T. Y. O.
    Mehta, R.
    Gane, E.
    Flaherty, J. F.
    Massetto, B.
    Kitrinos, K.
    Dinh, P.
    Subramanian, G. M.
    Mchutchison, J. G.
    Lim, Y. S.
    Acharya, S. K.
    Agarwal, K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 82 - 82
  • [49] A phase 3 study comparing switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): final week 96 efficacy and safety results
    Lampertico, Pietro
    Buti, Maria
    Ramji, Alnoor
    Fung, Scott
    Ahn, Sang Hoon
    Chuang, Wan-Long
    Yoon, Seung Kew
    Kao, Jia-Horng
    Chen, Chi-Yi
    Tam, Edward
    Khalili, Mandana
    Bae, Ho
    Ma, Xiaoli
    Tak, Won Young
    Flaherty, John F.
    Gaggar, Anuj
    Suri, Vithika
    Tan, Susanna
    Liu, Yang
    Wu, George
    Subramanian, Mani
    Hann, Hie-Won
    Agarwal, Kosh
    Lim, Young-Suk
    Chan, Henry
    JOURNAL OF HEPATOLOGY, 2020, 73 : S67 - S68
  • [50] EFFECTIVENESS OF AND PREDICTORS ASSOCIATED WITH VIROLOGIC RESPONSE TO TENOFOVIR ALAFENAMIDE (TAF) IN NUCLEOSIDE (TIDE) ANALOGUE (NA) TREATMENT NAIVE PATIENTS WITH CHRONIC HEPATITIS B (CHB) IN CHINA
    Chen, Peng
    Xu, Liang
    Kuai, Wentao
    Wei, Wei
    Liu, Huan
    Zhu, Yu
    HEPATOLOGY, 2021, 74 : 478A - 479A
12345